Dr. Kass is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
309 W Quinto St
Santa Barbara, CA 93105Phone+1 805-563-0041Fax+1 805-898-3614
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1987 - 1990
Yale-New Haven Medical CenterResidency, Internal Medicine, 1987- Yale-New Haven Medical CenterInternship, Internal Medicine, 1984 - 1985
Tufts University School of MedicineClass of 1984
Certifications & Licensure
CA State Medical License 1990 - 2025- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Start of enrollment: 2008 Nov 10
- Docetaxel, Carboplatin, and Trastuzumab and/or Lapatinib in Treating Women With Stage I, Stage II, or Stage III Breast Cancer That Can Be Removed by Surgery Start of enrollment: 2009 Apr 01
- Everolimus in Treating Patients With Previously Treated Unresectable or Metastatic Esophageal Cancer or Stomach Cancer Start of enrollment: 2009 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- 18 citationsA Noninvasive Blood-based Combinatorial Proteomic Biomarker Assay to Detect Breast Cancer in Women Under the Age of 50 YearsAna Lourenço, Kasey Benson, Meredith C. Henderson, Michael Silver, Elias Letsios
Clinical Breast Cancer. 2017-05-23 - 2 citationsCardiac safety results from a phase II, open-label, multicenter, pilot study of two docetaxel-based regimens plus bevacizumab for the adjuvant treatment of subjects wi...Sara A. Hurvitz, Linda D. Bosserman, David Chan, Christopher T Hagenstad, Frederick C Kass
Springerplus. 2014-05-12 - 79 citationsDifferential response of triple-negative breast cancer to a docetaxel and carboplatin-based neoadjuvant treatment.Helena R. Chang, John A. Glaspy, Mary Ann Allison, Frederic C. Kass, Robert Elashoff
Cancer. 2010-09-15
Research History
- Director of Research, Cancer Center of Santa Barbara1990 - Present
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
